These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3300969)

  • 41. [Impact of perioperative chemotherapy on prognosis of colorectal cancer: a report of 82 cases].
    Gong ZJ; Ren JQ; Kong G; Qing DJ; Liu H; Liang YQ
    Ai Zheng; 2007 Dec; 26(12):1350-3. PubMed ID: 18076799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny N; Lynch G; Wookcock T
    Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
    [No Abstract]   [Full Text] [Related]  

  • 43. Phase II trial of esorubicin in patients with advanced melanoma.
    Frustaci S; Gasparini G; Galligioni E; Tirelli U; Di Pietro N; Crivellari D; Lo Re G; Monfardini S
    Cancer Treat Rep; 1987 Mar; 71(3):325-6. PubMed ID: 3815399
    [No Abstract]   [Full Text] [Related]  

  • 44. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer.
    Madajewicz S; Petrelli N; Rustum YM; Campbell J; Herrera L; Mittelman A; Perry A; Creaven PJ
    Cancer Res; 1984 Oct; 44(10):4667-9. PubMed ID: 6331882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
    Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
    Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer.
    Buroker T; Miller A; Baker L; McKenzie M; Samson M; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1579-80. PubMed ID: 336199
    [No Abstract]   [Full Text] [Related]  

  • 47. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
    Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
    Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 49. Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
    Carroll DS; Gralla RJ; Kemeny NE
    Cancer Treat Rep; 1979; 63(11-12):2097-8. PubMed ID: 526944
    [No Abstract]   [Full Text] [Related]  

  • 50. Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.
    Carlson RW; Billingham ME; Kohler M; Johnson FD; Doroshow JH; Torti FM
    Cancer Treat Rep; 1987 Apr; 71(4):427-8. PubMed ID: 3548961
    [No Abstract]   [Full Text] [Related]  

  • 51. Carboplatin for advanced colorectal carcinoma: a phase II study.
    Perry DJ; Weiss RB; Creekmore SP; Micetich KC; Curt GA
    Cancer Treat Rep; 1986 Feb; 70(2):301-2. PubMed ID: 3512081
    [No Abstract]   [Full Text] [Related]  

  • 52. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Casper E
    Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
    Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
    Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
    Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
    Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
    Tchekmedyian NS; Kaplan RS; Eisenberger M; Abrams J; Van Echo D
    Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
    [No Abstract]   [Full Text] [Related]  

  • 56. Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.
    Tauer K; Kemeny N; Cheng E; Hollander P; Geller N
    Cancer Treat Rep; 1986 Jun; 70(6):813-4. PubMed ID: 3524831
    [No Abstract]   [Full Text] [Related]  

  • 57. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
    Lillis PK; Brown TD; Beougher K; Koeller J; Marcus SG; Von Hoff DD
    Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Phase II study of THP (2''R)-4'-0-tetrahydropyranyladriamycin) in breast cancer].
    Abe O; Enomoto K; Tominaga T; Kasai Y; Soejima S; Kasai M; Izuo M; Yoshida M; Kubo K; Terasawa T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):578-85. PubMed ID: 3954379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer].
    Asano M; Mori T; Takahashi K; Yasuno M
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):55-60. PubMed ID: 9020946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Early postoperative intraperitoneal perfusion chemotherapy for advanced colorectal cancer].
    Sun N; Cai Z; Zhang C
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):222-4. PubMed ID: 10921014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.